Leidos

Leidos is part of the joint venture that manages and operates the Y-12 National Security Complex and, until October 2024, the Pantex Plant, where U.S. nuclear weapons are assembled.

Nuclear Weapons |  Investments

Company Profile

Leidos is a U.S.-based company active in defence, intelligence, civil, and health markets.[i] Its defence sector activities include “enterprise and mission IT, large-scale intelligence systems, command and control, geospatial and data analytics, cybersecurity, logistics, training, and intelligence analysis and operations support”.[ii] Leidos is part of the joint venture that manages and operates the Y-12 National Security Complex and, until October 2024, the Pantex Plant, where U.S. nuclear weapons are assembled.  In the financial year ending 29 December 2023, Leidos generated revenues of $15.4. billion.[iii]

[i] Company (no date) | Leidos. Available at: https://www.leidos.com/company (Accessed: 6 December 2024).

[ii] Markets (no date) | Leidos. Available at: Markets | Leidos (Accessed: 6 December 2024).

[iii] ‘2023 Annual Report’, Leidos (2024), p. 54. Available at: LDOS 12.29.2023 FORM 10-K.

Contact information

Leonardo SpA

Registered Head Office:

Piazza Monte Grappa n. 4,
00195 Roma

Italy

Website: Aerospace, Defence and Security | Leonardo

X: @Leonardo_live

LinkedIn: Leonardo | LinkedIn

 

 

Nuclear Weapons

Leidos is part of the Consolidated Nuclear Security (CNS), LLC joint venture that manages and operates the Y-12 National Security Complex and, until October 2024, the Pantex Plant[i], where U.S. nuclear weapons are assembled.[ii]  The Y-12 Complex is responsible for the remanufacture of components for the B61-12 nuclear gravity bomb, and the Pantex Plant for producing high explosives, requalifying the B61 pit, and final assembly of the complete B61-12 bomb for delivery to the U.S. Air Force.[iii] The Y-12 Complex and Pantex Plant also pay a key role in the W88 nuclear warhead alteration (deployed on the Trident II D5 missile)[iv], the W80 life extension program (for use in the U.S. Long Range Standoff Weapon)[v] and the W87 warhead modification (to be fielded on the new U.S. ICBM)[vi], through the production of weapon and uranium components, and detonators, and high explosives respectively. The contract held by CNS is potentially valued at $49.8 billion. [vii]

[i] NNSA awards Pantex Management and Operating contract . Energy.gov, 13 June 2024. Available at: NNSA awards Pantex Management and Operating contract  | Department of Energy; ‘PanTeXas Deterrence assumes leadership at Pantex Plant under new 20-year contract’, Amarillo Globe-News, 7 November 2024. Available at: PanTeXas Deterrence assumes leadership at Pantex Plant.

[ii] About (no date) | Consolidated Nuclear Security, LLC. Available at: https://cns-llc.us/about (Accessed: 6 December 2024);

‘Fiscal Year 2024 Stockpile Stewardship and Management Plan’, National Nuclear Security Administration (2023), pp. F-61 – F-64. Available at: FY24SSMP_FINAL_NOVEMBER_2023_0.pdf (energy.gov).

[iii] ‘B61-12 Life Extension Program’ (2023). National Nuclear Security Administration. Available at: https://www.energy.gov/sites/default/files/2023-04/B61-12%20042023.pdf.

[iv] W88 Alteration 370 Program’ (2023). National Nuclear Security Administration. Available at: https://www.energy.gov/sites/default/files/2023-11/W88-ALT370_1123.pdf.

[v] ‘W80-4 Life Extension Program’ (2023). National Nuclear Security Administration. Available at: W80-4_1123.pdf.

[vi] ‘W87-1 Modification Program’ (2023).  National Nuclear Security Administration. Available at: W87-1_1123.pdf.

[vii] Contract No. DE-NA0001942 (2018) Energy.gov. Section J, Appendix A, Page 1. Available at: https://www.energy.gov/nnsa/downloads/contract-no-de-na0001942 (Accessed: 6 December 2024);
CONTRACT to CONSOLIDATED NUCLEAR SECURITY LLC. | USAspending’, 8 January 2013. Available at: https://www.usaspending.gov/award/CONT_AWD_DENA0001942_8900_-NONE-_-NONE- (Accessed: 6 December 2024).

Investments

Last updated: 2025-02-27 19:20:51

Notes